Overview |
bsm-90271R |
IL13 receptor alpha 1 Recombinant Antbody Kit (KD-Validated) |
WB, FCM, IC |
Knockdown Validated |
Human |
Specifications |
Unconjugated |
Rabbit |
A synthesized peptide derived from human IL13 receptor alpha 1 |
50-101/427 |
Monoclonal |
IgG |
Lot dependent |
Affinity Purified |
0.01M TBS (pH 7.4), 1% BSA, 0.02% Proclin 300, and 50% Glycerol |
-20 °C |
Target |
3597 |
P78552 |
IL13RA1; Interleukin 13 Receptor Subunit Alpha 1; CD213a1 Antigen; IL-13Ra; CD213a1; NR4; Interleukin-13 Receptor Subunit Alpha-1; Interleukin 13 Receptor Alpha 1; IL-13 Receptor Subunit Alpha-1; IL13 Receptor Alpha-1 Chain; Cancer/Testis Antigen 19; IL-13R Subunit Alpha-1; CT19; IL-13R-Alpha-1; IL-13RA1; IL13RA; IL13R |
Cell Line: Hela Knockdown technology: shRNA Knockdown |
Application Dilution |
WB |
1:300-5000 |
FCM |
1:20-100 |
IC |
1:1000 |